Postremission Consolidation by Autologous Hematopoietic Cell Transplantation (HCT) for Acute Myeloid Leukemia in First Complete Remission (CR) and Negative Implications for Subsequent Allogeneic HCT in Second CR: A Study by the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)

J.R. Passweg; M. Labopin; M. Christopeit; J. Cornelissen; T. Pabst; G. Socié; N. Russel; I. yakoub-Agha; D. Blaise; T. Gedde-Dahl; H. Labussière-Wallet; R. Malladi; E. Forcade; S. Maury; E. Polge; F. Lanza; N.C. Gorin; M. Mohty; A. Nagler

doi:10.1016/j.bbmt.2019.11.021

Journal articles

Postremission Consolidation by Autologous Hematopoietic Cell Transplantation (HCT) for Acute Myeloid Leukemia in First Complete Remission (CR) and Negative Implications for Subsequent Allogeneic HCT in Second CR: A Study by the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)

Document type :

Journal articles

Domain :

Life Sciences [q-bio] / Immunology

Complete list of metadata

https://hal-amu.archives-ouvertes.fr/hal-03152838
Contributor : Jacques Nunès Connect in order to contact the contributor
Submitted on : Thursday, February 25, 2021 - 8:23:00 PM
Last modification on : Thursday, March 17, 2022 - 9:30:03 AM

J.R. Passweg, M. Labopin, M. Christopeit, J. Cornelissen, T. Pabst, et al.. Postremission Consolidation by Autologous Hematopoietic Cell Transplantation (HCT) for Acute Myeloid Leukemia in First Complete Remission (CR) and Negative Implications for Subsequent Allogeneic HCT in Second CR: A Study by the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT). Biology of Blood and Marrow Transplantation, Elsevier, 2020, 26 (4), pp.659-664. ⟨10.1016/j.bbmt.2019.11.021⟩. ⟨hal-03152838⟩

Links full text

Identifiers

Collections

Citation

Export

Metrics

29